Cargando…

Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma

SARS-CoV-2 viral contagion has given rise to a worldwide pandemic. Although most children experience minor symptoms from SARS-CoV-2 infection, some have severe complications including Multisystem Inflammatory Syndrome in Children. Neuroblastoma patients may be at higher risk of severe infection as t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergsneider, Brandon, Bailey, Elise, Ahmed, Yusuf, Gogineni, Namrata, Huntley, Derek, Montano, Ximena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286873/
https://www.ncbi.nlm.nih.gov/pubmed/34307909
http://dx.doi.org/10.1016/j.bbrep.2021.101081
_version_ 1783723803785822208
author Bergsneider, Brandon
Bailey, Elise
Ahmed, Yusuf
Gogineni, Namrata
Huntley, Derek
Montano, Ximena
author_facet Bergsneider, Brandon
Bailey, Elise
Ahmed, Yusuf
Gogineni, Namrata
Huntley, Derek
Montano, Ximena
author_sort Bergsneider, Brandon
collection PubMed
description SARS-CoV-2 viral contagion has given rise to a worldwide pandemic. Although most children experience minor symptoms from SARS-CoV-2 infection, some have severe complications including Multisystem Inflammatory Syndrome in Children. Neuroblastoma patients may be at higher risk of severe infection as treatment requires immunocompromising chemotherapy and SARS-CoV-2 has demonstrated tropism for nervous cells. To date, there is no sufficient epidemiological data on neuroblastoma patients with SARS-CoV-2. Therefore, we evaluated datasets of non-SARS-CoV-2 infected neuroblastoma patients to assess for key genes involved with SARS-CoV-2 infection as possible neuroblastoma prognostic and infection biomarkers. We hypothesized that ACE2, CD147, PPIA and PPIB, which are associated with viral-cell entry, are potential biomarkers for poor prognosis neuroblastoma and SARS-CoV-2 infection. We have analysed three publicly available neuroblastoma gene expression datasets to understand the specific molecular susceptibilities that high-risk neuroblastoma patients have to the virus. Gene Expression Omnibus (GEO) GSE49711 and GEO GSE62564 are the microarray and RNA-Seq data, respectively, from 498 neuroblastoma samples published as part of the Sequencing Quality Control initiative. TARGET, contains microarray data from 249 samples and is part of the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative. ACE2, CD147, PPIA and PPIB were identified through their involvement in both SARS-CoV-2 infection and cancer pathogenesis. In-depth statistical analysis using Kaplan-Meier, differential gene expression, and Cox multivariate regression analysis, demonstrated that overexpression of ACE2, CD147, PPIA and PPIB is significantly associated with poor-prognosis neuroblastoma samples. These results were seen in the presence of amplified MYCN, unfavourable tumour histology and in patients older than 18 months of age. Previously, we have shown that high levels of the nerve growth factor receptor NTRK1 together with low levels of the phosphatase PTPN6 and TP53 are associated with increased relapse-free survival of neuroblastoma patients. Interestingly, low levels of expression of ACE2, CD147, PPIA and PPIB are associated with this NTRK1-PTPN6-TP53 module, suggesting that low expression levels of these genes are associated with good prognosis. These findings have implications for clinical care and therapeutic treatment. The upregulation of ACE2, CD147, PPIA and PPIB in poor-prognosis neuroblastoma samples suggests that these patients may be at higher risk of severe SARS-CoV-2 infection. Importantly, our findings reveal ACE2, CD147, PPIA and PPIB as potential biomarkers and therapeutic targets for neuroblastoma.
format Online
Article
Text
id pubmed-8286873
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82868732021-07-20 Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma Bergsneider, Brandon Bailey, Elise Ahmed, Yusuf Gogineni, Namrata Huntley, Derek Montano, Ximena Biochem Biophys Rep Short Communication SARS-CoV-2 viral contagion has given rise to a worldwide pandemic. Although most children experience minor symptoms from SARS-CoV-2 infection, some have severe complications including Multisystem Inflammatory Syndrome in Children. Neuroblastoma patients may be at higher risk of severe infection as treatment requires immunocompromising chemotherapy and SARS-CoV-2 has demonstrated tropism for nervous cells. To date, there is no sufficient epidemiological data on neuroblastoma patients with SARS-CoV-2. Therefore, we evaluated datasets of non-SARS-CoV-2 infected neuroblastoma patients to assess for key genes involved with SARS-CoV-2 infection as possible neuroblastoma prognostic and infection biomarkers. We hypothesized that ACE2, CD147, PPIA and PPIB, which are associated with viral-cell entry, are potential biomarkers for poor prognosis neuroblastoma and SARS-CoV-2 infection. We have analysed three publicly available neuroblastoma gene expression datasets to understand the specific molecular susceptibilities that high-risk neuroblastoma patients have to the virus. Gene Expression Omnibus (GEO) GSE49711 and GEO GSE62564 are the microarray and RNA-Seq data, respectively, from 498 neuroblastoma samples published as part of the Sequencing Quality Control initiative. TARGET, contains microarray data from 249 samples and is part of the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative. ACE2, CD147, PPIA and PPIB were identified through their involvement in both SARS-CoV-2 infection and cancer pathogenesis. In-depth statistical analysis using Kaplan-Meier, differential gene expression, and Cox multivariate regression analysis, demonstrated that overexpression of ACE2, CD147, PPIA and PPIB is significantly associated with poor-prognosis neuroblastoma samples. These results were seen in the presence of amplified MYCN, unfavourable tumour histology and in patients older than 18 months of age. Previously, we have shown that high levels of the nerve growth factor receptor NTRK1 together with low levels of the phosphatase PTPN6 and TP53 are associated with increased relapse-free survival of neuroblastoma patients. Interestingly, low levels of expression of ACE2, CD147, PPIA and PPIB are associated with this NTRK1-PTPN6-TP53 module, suggesting that low expression levels of these genes are associated with good prognosis. These findings have implications for clinical care and therapeutic treatment. The upregulation of ACE2, CD147, PPIA and PPIB in poor-prognosis neuroblastoma samples suggests that these patients may be at higher risk of severe SARS-CoV-2 infection. Importantly, our findings reveal ACE2, CD147, PPIA and PPIB as potential biomarkers and therapeutic targets for neuroblastoma. Elsevier 2021-07-19 /pmc/articles/PMC8286873/ /pubmed/34307909 http://dx.doi.org/10.1016/j.bbrep.2021.101081 Text en © 2021 Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Short Communication
Bergsneider, Brandon
Bailey, Elise
Ahmed, Yusuf
Gogineni, Namrata
Huntley, Derek
Montano, Ximena
Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma
title Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma
title_full Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma
title_fullStr Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma
title_full_unstemmed Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma
title_short Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma
title_sort analysis of sars-cov-2 infection associated cell entry proteins ace2, cd147, ppia, and ppib in datasets from non sars-cov-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286873/
https://www.ncbi.nlm.nih.gov/pubmed/34307909
http://dx.doi.org/10.1016/j.bbrep.2021.101081
work_keys_str_mv AT bergsneiderbrandon analysisofsarscov2infectionassociatedcellentryproteinsace2cd147ppiaandppibindatasetsfromnonsarscov2infectedneuroblastomapatientsaspotentialprognosticandinfectionbiomarkersinneuroblastoma
AT baileyelise analysisofsarscov2infectionassociatedcellentryproteinsace2cd147ppiaandppibindatasetsfromnonsarscov2infectedneuroblastomapatientsaspotentialprognosticandinfectionbiomarkersinneuroblastoma
AT ahmedyusuf analysisofsarscov2infectionassociatedcellentryproteinsace2cd147ppiaandppibindatasetsfromnonsarscov2infectedneuroblastomapatientsaspotentialprognosticandinfectionbiomarkersinneuroblastoma
AT gogineninamrata analysisofsarscov2infectionassociatedcellentryproteinsace2cd147ppiaandppibindatasetsfromnonsarscov2infectedneuroblastomapatientsaspotentialprognosticandinfectionbiomarkersinneuroblastoma
AT huntleyderek analysisofsarscov2infectionassociatedcellentryproteinsace2cd147ppiaandppibindatasetsfromnonsarscov2infectedneuroblastomapatientsaspotentialprognosticandinfectionbiomarkersinneuroblastoma
AT montanoximena analysisofsarscov2infectionassociatedcellentryproteinsace2cd147ppiaandppibindatasetsfromnonsarscov2infectedneuroblastomapatientsaspotentialprognosticandinfectionbiomarkersinneuroblastoma